Actively Recruiting
Comparative Effects of Alternate Nostril Breathing Versus Buteyko Breathing on Control Pause, Dyspnea, and Pulmonary Function in Patients With Bronchial Asthma
Led by Foundation University Islamabad · Updated on 2026-04-14
46
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Bronchial asthma is a long-term inflammatory disease of the airways causing repeated episodes of shortness of breath, wheezing, and airflow limitation. Dysfunctional breathing patterns and chronic hyperventilation often worsen symptoms and reduce asthma control. This study is comparing two breathing techniques, Alternate Nostril Breathing and Buteyko Breathing, to evaluate their effects on control pause, dyspnea, pulmonary function, and asthma management in patients with bronchial asthma. The study will include 40 patients with mild to moderate persistent asthma who will be randomly assigned to one of two groups. One group will practice Alternate Nostril Breathing, while the other group will learn the Buteyko Breathing Technique. Both groups will continue their usual asthma medications as prescribed by their pulmonologist. The intervention lasts four weeks, including two supervised sessions per week and five additional home sessions weekly, each lasting 10-15 minutes, supported by home exercise diaries to monitor adherence. Participants will be evaluated over the four-week period for changes in control pause (a breath-holding measure), dyspnea symptoms, lung function tests, and overall asthma control. Assessments and monitoring will be conducted regularly to track breathing improvements and symptom changes. The study aims to provide insight into how these breathing exercises may impact asthma control alongside standard treatment.
CONDITIONS
Brief Title
Comparative Effects of Alternative Nostril Breathing Versus Buteyko Breathing on Control Pause, Dyspnea and Pulmonary Function in Patients With Bronchial Asthma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 45 years
- Both male and female participants
- Grade 1 to 3 on mMRC scale of dyspnea
- Mild persistent, moderate persistent, or intermediate asthma severity according to NAEPP 2020 guidelines
You will not qualify if you...
- Acute exacerbation of COPD or status asthmaticus
- Acute infection diagnosis
- Inability to follow commands or instructions
- Asthma patients with control pause duration greater than 40 seconds
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 4 weeks
Participants receive either Alternate Nostril Breathing or Buteyko Breathing Technique along with standard pharmacological management. The breathing interventions include supervised sessions with a physiotherapist and additional home-based sessions.
2 supervised sessions per week and 5 home sessions per week
Trial Site Locations
Total: 1 location
1
Foundation University Islamabad
Islamabad, Pakistan
Actively Recruiting
Research Team
M
Maryam Arooj, MSPT-CPPT
Z
Zara Khalid, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here